Literature DB >> 23335749

A novel role for IL-27 in mediating the survival of activated mouse CD4 T lymphocytes.

Gisen Kim1, Ryo Shinnakasu, Christiaan J M Saris, Hilde Cheroutre, Mitchell Kronenberg.   

Abstract

IL-27, an IL-12 family cytokine, has pleiotropic functions in the differentiation and expansion of CD4(+) T cell subsets. In this study, we discovered a novel function of IL-27. CD4(+)CD45RB(high) T cells from mice deficient for the α-chain of IL-27 receptor failed to induce colitis in Rag(-/-) recipients, because of an inability of activated donor cells to survive. Interestingly, IL-27 was indispensable for the prevention of colitis by regulatory T cells, also because of a defect in long-term cell survival. IL-27 affected the survival of activated T lymphocytes, rather than promoting cell proliferation, by inhibiting Fas-mediated activation-induced T cell death, acting through the STAT3 signaling pathway. The addition of IL-27 during activation resulted in an increased cell number, which was correlated with decreased activation of both caspases 3 and 8. This prosurvival effect was attributed to downregulation of FasL and to the induction of the antiapoptotic protein cFLIP. Although activation induced cell death is an important mechanism for the maintenance of immunological homeostasis, protection of lymphocytes from excessive cell death is essential for effective immunity. Our data indicate that IL-27 has a crucial role in the inhibition of activation-induced cell death, thereby permitting Ag-driven T cell expansion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335749      PMCID: PMC4060896          DOI: 10.4049/jimmunol.1201017

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

Authors:  J P Medema; C Scaffidi; F C Kischkel; A Shevchenko; M Mann; P H Krammer; M E Peter
Journal:  EMBO J       Date:  1997-05-15       Impact factor: 11.598

2.  Cloning and characterization of a novel class I cytokine receptor.

Authors:  C A Sprecher; F J Grant; J W Baumgartner; S R Presnell; S K Schrader; T Yamagiwa; T E Whitmore; P J O'Hara; D F Foster
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

Review 3.  Regulatory T cells and intestinal homeostasis.

Authors:  Janine L Coombes; Nicholas J Robinson; Kevin J Maloy; Holm H Uhlig; Fiona Powrie
Journal:  Immunol Rev       Date:  2005-04       Impact factor: 12.988

4.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

5.  Cutting edge: CD4+CD25+ regulatory T cells impaired for intestinal homing can prevent colitis.

Authors:  Timothy L Denning; Gisen Kim; Mitchell Kronenberg
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

6.  Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.

Authors:  R Aranda; B C Sydora; P L McAllister; S W Binder; H Y Yang; S R Targan; M Kronenberg
Journal:  J Immunol       Date:  1997-04-01       Impact factor: 5.422

7.  Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis.

Authors:  Y Refaeli; L Van Parijs; C A London; J Tschopp; A K Abbas
Journal:  Immunity       Date:  1998-05       Impact factor: 31.745

8.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

9.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice.

Authors:  F Powrie; M W Leach; S Mauze; L B Caddle; R L Coffman
Journal:  Int Immunol       Date:  1993-11       Impact factor: 4.823

10.  CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+ T cells.

Authors:  P J Morrissey; K Charrier; S Braddy; D Liggitt; J D Watson
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  35 in total

1.  Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.

Authors:  Miranda L Hanson; Julie A Hixon; Wenqing Li; Barbara K Felber; Miriam R Anver; C Andrew Stewart; Brian M Janelsins; Sandip K Datta; Wei Shen; Mairi H McLean; Scott K Durum
Journal:  Gastroenterology       Date:  2013-10-09       Impact factor: 22.682

2.  Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.

Authors:  Xiaotong Zhu; Zhihao Liu; Jin-Qing Liu; Jianmin Zhu; Jianchao Zhang; Jonathan P Davis; Jianhong Chu; Jianhua Yu; Jie Zhou; Ming-Song Li; Xue-Feng Bai
Journal:  J Leukoc Biol       Date:  2016-04-22       Impact factor: 4.962

3.  Recruitment of IL-27-Producing CD4(+) T Cells and Effect of IL-27 on Pleural Mesothelial Cells in Tuberculous Pleurisy.

Authors:  Zhi-Jian Ye; Li-Li Xu; Qiong Zhou; Ai Cui; Xiao-Juan Wang; Kan Zhai; Zhen Wang; Zhao-Hui Tong; Huan-Zhong Shi
Journal:  Lung       Date:  2015-05-06       Impact factor: 2.584

4.  IL-27 and the generation of CD8+ T-cell responses to peptide vaccines.

Authors:  Timothy N J Bullock
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-17       Impact factor: 11.205

5.  IL-27 confers a protumorigenic activity of regulatory T cells via CD39.

Authors:  Young-Jun Park; Heeju Ryu; Garam Choi; Byung-Seok Kim; Eun Sook Hwang; Hun Sik Kim; Yeonseok Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

Review 6.  Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.

Authors:  Caroline Andrews; Mairi H McLean; Scott K Durum
Journal:  Inflamm Bowel Dis       Date:  2016-09       Impact factor: 5.325

7.  IL-27 is required for shaping the magnitude, affinity distribution, and memory of T cells responding to subunit immunization.

Authors:  Nathan D Pennock; Laurent Gapin; Ross M Kedl
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

8.  Interleukin-27 signalling induces stem cell antigen-1 expression in T lymphocytes in vivo.

Authors:  Zhihao Liu; Lisha Wu; Jing Zhu; Xiaotong Zhu; Jianmin Zhu; Jin-Qing Liu; Jianchao Zhang; Jonathan P Davis; Sanjay Varikuti; Abhay R Satoskar; Jie Zhou; Ming-Song Li; Xue-Feng Bai
Journal:  Immunology       Date:  2017-08-23       Impact factor: 7.397

9.  Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression.

Authors:  Ludovic Belle; Kimberle Agle; Vivian Zhou; Cheng Yin-Yuan; Richard Komorowski; Daniel Eastwood; Brent Logan; Jie Sun; Nico Ghilardi; Daniel Cua; Calvin B Williams; Melanie Gaignage; Reece Marillier; Jacques van Snick; William R Drobyski
Journal:  Blood       Date:  2016-08-03       Impact factor: 22.113

Review 10.  IL-27-induced modulation of autoimmunity and its therapeutic potential.

Authors:  Rakeshchandra R Meka; Shivaprasad H Venkatesha; Steven Dudics; Bodhraj Acharya; Kamal D Moudgil
Journal:  Autoimmun Rev       Date:  2015-08-05       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.